500 related articles for article (PubMed ID: 17179390)
1. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification.
Bruce CR; Brolin C; Turner N; Cleasby ME; van der Leij FR; Cooney GJ; Kraegen EW
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1231-7. PubMed ID: 17179390
[TBL] [Abstract][Full Text] [Related]
2. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle.
Kim JY; Koves TR; Yu GS; Gulick T; Cortright RN; Dohm GL; Muoio DM
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1014-22. PubMed ID: 11934665
[TBL] [Abstract][Full Text] [Related]
3. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.
Bruce CR; Thrush AB; Mertz VA; Bezaire V; Chabowski A; Heigenhauser GJ; Dyck DJ
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E99-E107. PubMed ID: 16464906
[TBL] [Abstract][Full Text] [Related]
4. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
5. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
Sugden MC; Priestman DA; Orfali KA; Holness MJ
Horm Metab Res; 1999 May; 31(5):300-6. PubMed ID: 10422724
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CPT I activity in intermyofibrillar and subsarcolemmal mitochondria from human and rat skeletal muscle.
Bezaire V; Heigenhauser GJ; Spriet LL
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E85-91. PubMed ID: 12954596
[TBL] [Abstract][Full Text] [Related]
7. Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA.
Holness MJ; Priestman DA; Sugden MC
J Mol Cell Cardiol; 1998 Jul; 30(7):1381-90. PubMed ID: 9710806
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats.
Steinberg GR; Bonen A; Dyck DJ
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E593-600. PubMed ID: 11832362
[TBL] [Abstract][Full Text] [Related]
9. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
[TBL] [Abstract][Full Text] [Related]
10. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I.
Zhu H; Shi J; de Vries Y; Arvidson DN; Cregg JM; Woldegiorgis G
Arch Biochem Biophys; 1997 Nov; 347(1):53-61. PubMed ID: 9344464
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
12. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
Aires CC; Ijlst L; Stet F; Prip-Buus C; de Almeida IT; Duran M; Wanders RJ; Silva MF
Biochem Pharmacol; 2010 Mar; 79(5):792-9. PubMed ID: 19854160
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise.
Holloway GP; Bezaire V; Heigenhauser GJ; Tandon NN; Glatz JF; Luiken JJ; Bonen A; Spriet LL
J Physiol; 2006 Feb; 571(Pt 1):201-10. PubMed ID: 16357012
[TBL] [Abstract][Full Text] [Related]
15. Carnitine palmitoyltransferase I (CPT I) activity and its regulation by malonyl-CoA are modulated by age and cold exposure in skeletal muscle mitochondria from newborn pigs.
Schmidt I; Herpin P
J Nutr; 1998 May; 128(5):886-93. PubMed ID: 9566999
[TBL] [Abstract][Full Text] [Related]
16. Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells.
Peluso G; Petillo O; Margarucci S; Grippo P; Melone MA; Tuccillo F; Calvani M
J Cell Physiol; 2005 May; 203(2):439-46. PubMed ID: 15515015
[TBL] [Abstract][Full Text] [Related]
17. Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation.
Bentebibel A; Sebastián D; Herrero L; López-Viñas E; Serra D; Asins G; Gómez-Puertas P; Hegardt FG
Biochemistry; 2006 Apr; 45(14):4339-50. PubMed ID: 16584169
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.
Paul HS; Adibi SA
J Clin Invest; 1979 Aug; 64(2):405-12. PubMed ID: 457859
[TBL] [Abstract][Full Text] [Related]
19. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
[TBL] [Abstract][Full Text] [Related]
20. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
